@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix go: . @prefix scomp: . @prefix ProteinComplex: . @prefix hasAgent: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { scomp:Nfkb%20Complex a ProteinComplex: . sub:_1 geneProductOf: hgnc:9607; a Protein: . sub:_2 hasAgent: scomp:Nfkb%20Complex; a go:0042789 . sub:_3 occursIn: obo:CL_0000192, obo:UBERON_0004535, species:9606; rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(HGNC:PTHLH) -> tscript(complex(SCOMP:\"Nfkb Complex\"))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "20131211" . sub:_4 dce:identifier "AHA Abstracts 351"; dce:title "AHA Abstracts 351"; dce:type "Other" . sub:_5 prov:value "HMG-CoA reductase inhibitor, simvastatin, inhibited the effects of PTHrP (1-36) on both NF-kB activity and MCP-1 overexpression, and these effects were reversed by mevalonate."; prov:wasQuotedFrom sub:_4 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource sub:_4; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:31:26.670+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }